Phase 1 Start~month
Phase 1 Start: A Phase I/IIA Study Evaluating the Safety and Efficacy of NY-ESO-1TCR/dnTGFBRII Engineered T Cells i
Other upcoming events for FLNA
Phase 3 ReadoutPhase 3 Topline: A Randomized Phase 3 Trial of Vinorelbine, Dactinomycin, and Cyclophosphamide (VINO-AC) Plus Mainten
Phase 2 StartPhase 2 Start: Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positi
Phase 2 StartPhase 2 Start: A Multicenter, Open-label, Randomized Controlled Clinical Study Comparing the Efficacy and Safety of
Phase 3 ReadoutPhase 3 Topline: Haploidentical Allogeneic Peripheral Blood Transplantation: Clinical Trial and Laboratory Correlates
Patent ExpiryPatent/Exclusivity Expiry: LEGUBETI
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.